与舍格伦病相关的包涵体肌炎:临床特征及与其他舍格伦相关肌炎的对比
该回顾性多中心研究从法国13个中心纳入符合ACR/EULAR舍格伦病(SjD)和特发性炎症性肌病(IM)标准的患者,比较SjD合并包涵体肌炎(IBM)患者(n=22)与SjD合并其他IM患者(n=50)的临床特征。结果显示SjD-IBM患者以女性为主,肌肉表现类似经典散发性IBM;而腺外表现多、ESSDAI评分高、CPK>1000 UI/l及SjD诊断后肌炎发生间隔短则不支持IBM。
要点
- SjD-IBM患者多为女性(86%),首发IBM症状中位年龄62岁。
- SjD-IBM患者经典IBM特征常见:进行性起病59%、吞咽困难41%、低CPK和CRP。
- SjD合并其他IM患者更年轻、腺外表现更多、ESSDAI更高、CPK>1000 UI/l更常见。
核心结论
- IBM可发生于SjD患者,其肌肉特征类似经典散发性IBM,但主要影响女性。
- 在SjD伴肌肉受累的患者中,腺外表现、高ESSDAI评分、CPK升高及SjD诊断后较短间隔不支持IBM。
研究设计与样本
- 回顾性研究,从法国13个中心招募患者。
- 纳入标准为符合ACR/EULAR的SjD和IM标准。
- 符合IBM亚标准者归为SjD-IBM(n=22),否则归为SjD-其他IM(n=50)。
主要发现
- SjD-IBM患者(n=22)中女性占86%,SjD诊断中位年龄54[38.5;64]岁,首个IBM症状中位年龄62[46.5;70]岁。
- SjD-IBM患者ESSDAI中位5.5[1;7.8],进行性起病59%,非对称受累27%,远端受累32%,吞咽困难41%,CPK中位386.5[221.8;670.5]UI/l,CRP中位3.0[3;8.5]mg/l,免疫抑制剂报告有效者占55%。
- SjD-其他IM患者(n=50)较SjD-IBM患者显著更年轻,腺外表现更频繁,ESSDAI更高(11[3;30]),SjD诊断与肌炎发生间隔更短(0[-0.5;26]),CPK>1000 UI/l更常见(36%),经典IBM特征较少。
关键数值与推荐
- SjD-IBM定义:符合ACR/EULAR的SjD和IM标准,且满足IBM亚标准。
- SjD-其他IM定义:符合ACR/EULAR的SjD和IM标准,但不满足IBM亚标准。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe the characteristics of patients with Sjögren's disease (SjD) and inclusion-body myositis (IBM), and how they compare to SjD patients with other inflammatory myopathies (IM). METHODS: Patients were retrospectively recruited from 13 French centres and included if they met the ACR/EULAR criteria for SjD and for IM. They were categorized as SjD-IBM if sub-criteria for IBM were met, or as SjD-other IM if not. RESULTS: SjD-IBM patients (n = 22) were mostly females (86%), with a median [Q1; Q3] age of 54 [38.5; 64] years at SjD diagnosis, and 62 [46.5; 70] years at first IBM symptoms. Although most patients displayed glandular and immunological abnormalities, additional extra-glandular manifestations were uncommon, resulting in moderate disease activity at SjD diagnosis (ESSDAI 5.5 [1; 7.8]). Classic IBM features were frequent, such as progressive symptom onset (59%), asymmetrical (27%) and distal (32%) involvements, dysphagia (41%), low CPK (386.5 [221.8; 670.5] UI/l) and CRP (3.0 [3; 8.5] mg/l) levels. Immunosuppressants were reported as efficient in 55% of cases. Compared with SjD-IBM patients, SjD patients with other IM (n = 50) were significantly younger, displayed more frequent additional extra-glandular disease, higher ESSDAI score (11 [3; 30]), shorter delay between SjD diagnosis and myositis onset (0 [-0.5; 26]), more frequent CPK values over 1000 UI/l (36%), and less frequent classic IBM features. CONCLUSION: IBM can occur in SjD patients, with muscle features reminiscent of classic sporadic IBM characteristics, but mostly affecting women. In SjD patients with muscle involvement, extra-glandular manifestations, high ESSDAI score, elevated CPK values and shorter delay after SjD diagnosis plead against IBM.
引用
- Astouati Q, Machet T, Houssais C, et al. Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis. Rheumatology (Oxford). 2025. PMID: 38430004. doi:10.1093/rheumatology/keae129
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。